{"id":12913,"date":"2025-07-24T12:00:00","date_gmt":"2025-07-24T16:00:00","guid":{"rendered":"https:\/\/cov19longhaulfoundation.org\/?p=12913"},"modified":"2025-07-21T14:18:23","modified_gmt":"2025-07-21T18:18:23","slug":"%f0%9f%a7%ac-mechanisms-of-action-behind-covid-induced-hypersomnia","status":"publish","type":"post","link":"https:\/\/cov19longhaulfoundation.org\/?p=12913","title":{"rendered":"\ud83e\uddec Mechanisms of Action Behind COVID-Induced Hypersomnia"},"content":{"rendered":"\n

Hypersomnia<\/strong>, or excessive daytime sleepiness (EDS), has emerged as a notable neurological complication in some individuals following SARS-CoV-2 infection<\/strong>, particularly in the context of Long COVID<\/strong>. While fatigue is more commonly reported, hypersomnia represents a distinct clinical entity with unique underlying mechanisms.<\/p>\n\n\n\n

\ud83d\udd2c Etiology: How COVID Triggers Hypersomnia<\/h3>\n\n\n\n

1. Neuroinflammation and Autoimmunity<\/strong><\/h4>\n\n\n\n
    \n
  • COVID-19 can provoke autoimmune responses<\/strong> that target hypocretin (orexin)-producing neurons<\/strong> in the hypothalamus\u2014similar to mechanisms seen in narcolepsy type 1<\/strong>.<\/li>\n\n\n\n
  • Elevated IL-6 and TNF-\u03b1<\/strong> cytokines disrupt sleep-wake regulation by impairing hypothalamic and brainstem circuits.<\/li>\n<\/ul>\n\n\n\n

    2. Direct CNS Involvement<\/strong><\/h4>\n\n\n\n
      \n
    • SARS-CoV-2 may enter the brain via the olfactory pathway<\/strong>, affecting regions like the brainstem<\/strong>, thalamus<\/strong>, and temporal lobes<\/strong>, which are critical for arousal and sleep regulation.<\/li>\n\n\n\n
    • MRI and EEG studies have shown hypoperfusion<\/strong> in these areas during symptomatic hypersomnia episodes3.<\/li>\n<\/ul>\n\n\n\n

      3. Circadian Rhythm Disruption<\/strong><\/h4>\n\n\n\n
        \n
      • Lockdowns, isolation, and altered light exposure during the pandemic disrupted zeitgebers<\/strong> (external cues), leading to circadian misalignment<\/strong> and hypersomnolence.<\/li>\n<\/ul>\n\n\n\n

        4. Post-Infectious Encephalopathy<\/strong><\/h4>\n\n\n\n
          \n
        • Inflammatory damage to sleep-regulating centers<\/strong> may persist after acute infection, contributing to central hypersomnia<\/strong> even in mild COVID cases.<\/li>\n<\/ul>\n\n\n\n

          \ud83e\uddea Clinical Presentations<\/h3>\n\n\n\n
            \n
          • Idiopathic hypersomnia<\/strong>: Prolonged sleep duration (>11 hours\/day), sleep inertia, and non-restorative naps.<\/li>\n\n\n\n
          • Narcolepsy-like symptoms<\/strong>: Cataplexy, sleep attacks, and REM abnormalities in some post-COVID cases4.<\/li>\n\n\n\n
          • Kleine-Levin Syndrome (KLS)<\/strong>: Rare relapses triggered by COVID, with hypersomnia, hyperphagia, and mood changes.<\/li>\n<\/ul>\n\n\n\n

            Long COVID hypersomnia is driven by a complex interplay of neuroinflammation<\/strong>, autonomic dysfunction<\/strong>, and circadian disruption<\/strong>:<\/p>\n\n\n\n

              \n
            • Neuroinflammation<\/strong>: Elevated cytokines (IL-6, TNF-\u03b1) suppress wake-promoting neurons in the hypothalamus<\/strong> and brainstem<\/strong>, particularly those producing orexin<\/strong> (a key wakefulness neurotransmitter).<\/li>\n\n\n\n
            • Glymphatic system dysfunction<\/strong>: Impaired clearance of neurotoxins during sleep leads to brain fog<\/strong> and shutdown-like episodes.<\/li>\n\n\n\n
            • Vagus nerve dysregulation<\/strong>: COVID-related damage causes misfiring signals that disrupt sleep-wake cycles.<\/li>\n\n\n\n
            • Mitochondrial damage<\/strong>: Reduced cellular energy in neurons contributes to fatigue and hypersomnia.<\/li>\n\n\n\n
            • Persistent spike protein<\/strong>: May interfere with orexin signaling and hypothalamic function2.<\/li>\n<\/ul>\n\n\n\n

              \ud83e\udde0 Brain Function Changes and EEG Findings<\/h3>\n\n\n\n

              Recent studies using EEG, PET, and MRI<\/strong> have revealed measurable changes in brain activity among Long COVID hypersomnia patients:<\/p>\n\n\n\n

              Finding<\/strong><\/th>Implication<\/strong><\/th><\/tr><\/thead>
              \u2193 Nerve Growth Factor (NGF)<\/td>Reduced neuroplasticity and adaptability<\/td><\/tr>
              \u2191 IL-10 and IL-6<\/td>Ongoing inflammation in sleep-regulating centers<\/td><\/tr>
              \u2193 EEG alpha activity<\/td>Suggests reduced cortical arousal and alertness<\/td><\/tr>
              \u2191 NREM Stage 1 sleep<\/td>Increased drowsiness and fragmented sleep<\/td><\/tr>
              \u2193 REM and deep sleep stages<\/td>Poor sleep quality and unrefreshing rest<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

              These changes mirror patterns seen in early neurodegenerative disorders<\/strong>, raising concerns about long-term cognitive impact4.<\/p>\n\n\n\n

              \ud83e\ude7a Therapeutic Strategies in 2025<\/h3>\n\n\n\n

              \ud83d\udd39 Behavioral and Chronobiological Approaches<\/h4>\n\n\n\n
                \n
              • Cognitive Behavioral Therapy for Insomnia (CBT-I)<\/strong>: Effective for mixed insomnia\/hypersomnia phenotypes<\/li>\n\n\n\n
              • Light therapy + melatonin<\/strong>: Resets circadian rhythm and improves sleep onset<\/li>\n\n\n\n
              • Chronotherapy<\/strong>: Aligns medication timing with sleep cycles<\/li>\n<\/ul>\n\n\n\n

                \ud83d\udd39 Pharmacologic Interventions<\/h4>\n\n\n\n
                Agent<\/strong><\/th>Use Case<\/strong><\/th><\/tr><\/thead>
                Modafinil\/Solriamfetol<\/strong><\/td>Wakefulness promotion for hypersomnia<\/td><\/tr>
                Low-dose naltrexone (LDN)<\/strong><\/td>Immune modulation and sleep depth<\/td><\/tr>
                Oxybate (sodium oxybate)<\/strong><\/td>Improves sleep quality and inertia<\/td><\/tr>
                Methylphenidate<\/strong><\/td>Daytime alertness and cognitive clarity<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

                \ud83d\udd39 Emerging Therapies<\/h4>\n\n\n\n
                  \n
                • Orexin agonists<\/strong>: Target narcolepsy-like symptoms<\/li>\n\n\n\n
                • Vagus nerve stimulation<\/strong>: Rebalances autonomic dysfunction<\/li>\n\n\n\n
                • Mitochondrial support<\/strong>: CoQ10, NAD+, B vitamins for energy restoration<\/li>\n<\/ul>\n\n\n\n

                  \ud83d\udcc9 How Debilitating Is Long COVID Hypersomnia?<\/h3>\n\n\n\n
                    \n
                  • A 2025 meta-analysis in BMC Neurology<\/em> found 24.4%<\/strong> of Long COVID patients suffer from sleep disorders, with hypersomnia linked to significant activity limitations<\/strong>.<\/li>\n\n\n\n
                  • Case studies report school absenteeism<\/strong>, loss of productivity<\/strong>, and social withdrawal<\/strong> due to uncontrollable sleep episodes8.<\/li>\n\n\n\n
                  • Patients often experience brain fog<\/strong>, sleep inertia<\/strong>, and post-exertional crashes<\/strong>, resembling myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)<\/strong>.<\/li>\n<\/ul>\n\n\n\n

                    \ud83d\udd04 Is It Permanent?<\/h3>\n\n\n\n
                      \n
                    • Not always<\/strong>. Recovery depends on:\n
                        \n
                      • Severity of initial infection<\/li>\n\n\n\n
                      • Degree of neuroinflammation and microclot burden<\/li>\n\n\n\n
                      • Access to multidisciplinary care (e.g. RECOVER-SLEEP trial)<\/li>\n<\/ul>\n<\/li>\n\n\n\n
                      • A review in Current Sleep Medicine Reports<\/em> found that some patients recover within a year<\/strong>, while others require ongoing care and specialized therapies<\/strong>.<\/li>\n<\/ul>\n\n\n\n

                        \ud83d\udcda Peer-Reviewed Sources<\/h3>\n\n\n\n
                          \n
                        • RECOVER-SLEEP Trial Overview<\/li>\n\n\n\n
                        • Sudden Sleep Collapse: COVID Long Haul Foundation<\/li>\n\n\n\n
                        • Oxford Academic Case Report on Hypersomnia<\/li>\n\n\n\n
                        • BMC Neurology Meta-Analysis<\/li>\n\n\n\n
                        • Frontiers in Neurology Review<\/li>\n\n\n\n
                        • EurekAlert on ME\/CFS and Long COVID<\/li>\n\n\n\n
                        • PLOS One Brain Inflammation Study<\/li>\n\n\n\n
                        • MSU\/Corewell Health Brain Fog Study<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"

                          Hypersomnia, or excessive daytime sleepiness (EDS), has emerged as a notable neurological complication in some individuals following SARS-CoV-2 infection, particularly in the context of Long COVID. While fatigue is more […]<\/p>\n","protected":false},"author":2,"featured_media":12931,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1108,169,1299,887,536,949],"tags":[],"class_list":["post-12913","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-circadian-rhythm","category-fatigure","category-hypersomnia","category-narcolepsy","category-sleep","category-sleep-disturbance"],"_links":{"self":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/12913","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12913"}],"version-history":[{"count":2,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/12913\/revisions"}],"predecessor-version":[{"id":12915,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/12913\/revisions\/12915"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/media\/12931"}],"wp:attachment":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}